Health-related quality-of-life results for pembrolizumab versus placebo after complete resection of high-risk stage III melanoma from the EORTC 1325-MG/Keynote 054 trial: An international randomized double-blind phase III trial
Coens, C., Bottomley, A., Blank, C.U., Mandala, M., Long, G.V., Atkinson, V.G., Dalle, S., Haydon, A., Lichinitser, M., Khattak, A., Carlino, M.S., Sandhu, S.K., Larkin, J., Puig Sarda, S., Ascierto, P.A., Schadendorf, D., Ibrahim, N., Suciu, S., Robert, C., Eggermont, A.M.M.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
1123P Melanoma incidence and mortality decline in younger adults in Sweden: Start of a shift in the upgoing trend?
Helgadottir, H., Mikiver, R., Schultz, K., Nielsen, K., Portelli, F., Lapins, J., Puig Sarda, S., Isaksson, K.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
1095P Pembrolizumab versus placebo after a complete resection of high-risk stage III melanoma: 7-year results of the EORTC 1325-MG/Keynote-054 double-blind phase III trial
Eggermont, A.M.M., Kicinski, M., Blank, C.U., Mandalà, M., Long, G.V., Atkinson, V.G., Dalle, S., Haydon, A.M., Meshcheryakov, A., Khattak, M.A., Carlino, M.S., Sandhu, S.K., Puig Sarda, S., Ascierto, P.A., Lorigan, P., Grebennik, D., Krepler, C., Marreaud, S.I., Suciu, S., Robert, C.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
1152P Influence of dietary and physical exercise habits on the melanoma risk: A case-control study
Calbet-llopart, N., Moll-Amengual, R., Mateu, J., Potrony, M., Carrera, C., Iglesias, P., Tell-Marti, G., Sarda, S. Puig
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
1101P Efficacy of anti PD-1 therapy in children and adolescent melanoma patients (MELCAYA study)
Mandalà, M., Ferrari, A., Brecht, I., Suijkerbuijk, K., Maschke, L., Giannarelli, D., Indini, A., Ubaldi, M., Atkinson, V.G., Helgadottir, H., Chiaravalli, S., De Pasquale, M.D., Benannoune, N., Robert, C., Kosela Paterczyk, H.M., Puig Sarda, S., Massi, D., Long, G.V., Ascierto, P.A., Eggermont, A.M.M.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
LBA46 Pembrolizumab versus placebo after complete resection of high-risk stage III melanoma: Final results regarding distant metastasis-free survival from the EORTC 1325-MG/Keynote 054 double-blinded phase III trial
Eggermont, A.M.M., Blank, C.U., Mandala', M., Long, G.V., Atkinson, V., Dalle, S., Haydon, A.M., Meshcheryakov, A., Khattak, A., Carlino, M., Sandhu, S., Sarda, S. Puig, Ascierto, P.A., van Akkooi, A.C.J., Krepler, C., Ibrahim, N., Marreaud, S.I., Kicinski, M., Suciu, S., Robert, C.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
1278PHealth-related quality-of-life results for pembrolizumab versus placebo after complete resection of high-risk stage III melanoma from the EORTC 1325-MG/Keynote 054 trial: An international randomized double-blind phase III trial
Coens, C, Bottomley, A, Blank, C U, Mandala, M, Long, G V, Atkinson, V G, Dalle, S, Haydon, A, Lichinitser, M, Khattak, A, Carlino, M S, Sandhu, S K, Larkin, J, Puig Sarda, S, Ascierto, P A, Schadendorf, D, Ibrahim, N, Suciu, S, Robert, C, Eggermont, A M M
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Malignant head and neck melanoma
Garatea Crelgo, J, Puig Sardà, S, Gay Escoda, C
Published in Anales otorrinolaringologicos ibero-americanos (1994)
Get more information
Published in Anales otorrinolaringologicos ibero-americanos (1994)
Journal Article